2 research outputs found
Laparoskopik kolesistektomi sonrası ağrı tedavisinde hasta kontrollü analjezi yönteminde tramadole deksketoprofen trometamol eklenmesinin etkinliği
Objectives: Pain treatment in laparoscopic cholecystectomy, which is performed in increasing numbers as an ambulatory
procedure, is an important issue.Although laparoscopic cholecystectomy is regarded as an ambulatory procedure, patients
are often hospitalized due to pain and this increases opioid consumption and side effects caused by opioids. This study aims
at evaluating the efficacy of adding dexketoprofen trometamol to tramadol with patient controlled analgesia (PCA) in postlaparoscopic
cholecystectomy pain treatment.
Methods: 40 patients in ASA I-II risk groups aged between 18-65 years were enrolled in the study and were randomized
using closed envelope method. In Group TD 600 mg tramadol and 100 mg dexketoprofen trometamol, in Group T 600 mg
tramadol was added to 100 ml 0.9% normal saline for PCA. 8 mg lornoxicam iv was given if VAS >40 in the postoperative
period.
Results: There was no statistically significant difference in terms of adverse effects (hypotension, bradycardia, sedation) but in
Group T 4 patients complained of nausea and 3 complained of vomiting. Opioid consumption was lower and patient satisfaction
was higher in group TD.
Conclusion: This study has shown that adding dexketoprofen trometamol to tramadol in patient controlled analgesia following
laparoscopic cholecystectomy lowers VAS scores, increases patient satisfaction and decreases opioid consumption
The efficacy of adding dexketoprofen trometamol to tramadol with patient controlled analgesia technique in post-laparoscopic cholecystectomy pain treatment
Objectives: Pain treatment in laparoscopic cholecystectomy, which is performed in increasing numbers as an ambulatory
procedure, is an important issue.Although laparoscopic cholecystectomy is regarded as an ambulatory procedure, patients
are often hospitalized due to pain and this increases opioid consumption and side effects caused by opioids. This study aims
at evaluating the efficacy of adding dexketoprofen trometamol to tramadol with patient controlled analgesia (PCA) in postlaparoscopic
cholecystectomy pain treatment.
Methods: 40 patients in ASA I-II risk groups aged between 18-65 years were enrolled in the study and were randomized
using closed envelope method. In Group TD 600 mg tramadol and 100 mg dexketoprofen trometamol, in Group T 600 mg
tramadol was added to 100 ml 0.9% normal saline for PCA. 8 mg lornoxicam iv was given if VAS >40 in the postoperative
period.
Results: There was no statistically significant difference in terms of adverse effects (hypotension, bradycardia, sedation) but in
Group T 4 patients complained of nausea and 3 complained of vomiting. Opioid consumption was lower and patient satisfaction
was higher in group TD.
Conclusion: This study has shown that adding dexketoprofen trometamol to tramadol in patient controlled analgesia following
laparoscopic cholecystectomy lowers VAS scores, increases patient satisfaction and decreases opioid consumption